首页> 美国卫生研究院文献>The Journal of Experimental Medicine >Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection
【2h】

Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection

机译:重组鼠肿瘤坏死因子α/ Cachectin和鼠白细胞介素1α的预处理可保护小鼠免受致死性细菌感染

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tumor necrosis factor/cachectin (TNF/C) is the principal mediator of bacterial endotoxin-induced shock and death. We found that the C3H/HeJ mouse, which is less able to produce TNF/C in response to endotoxin, has a 1,000-fold greater susceptibility to lethal infection with Escherichia coli than the TNF-responsive congenic mouse, C3H/HeN. This surprising finding suggested that this lethal peptide may also be involved in host protection. To test this hypothesis we pretreated the C3H/HeJ mouse with a combination of recombinant murine TNF/C-alpha and IL-1 alpha. This combination protected these mice against an intraperitoneal bacterial challenge of greater than 20 LD50S (nearly 2 x 10(2) CFU) that grew to a level of greater than 10(7) CFU/ml of blood and per gram of liver in untreated mice. This suggests a significant role for these cytokines in host defenses against invasive infections that require bacterial replication within the host. These protective mechanisms may not be important for less virulent organisms. These findings may have important implications for the proposed use of anti- TNF/C agents in the treatment of septic shock.
机译:肿瘤坏死因子/ cachectin(TNF / C)是细菌内毒素引起的休克和死亡的主要介质。我们发现,C3H / HeJ小鼠对内毒素的反应能力较弱,无法产生TNF / C,其对致死性大肠杆菌感染的敏感性比对TNF反应的同系小鼠C3H / HeN高1,000倍。这一令人惊讶的发现表明该致死肽也可能参与宿主的保护。为了检验该假设,我们用重组鼠TNF /C-α和IL-1α的组合预处理了C3H / HeJ小鼠。这种组合可以保护这些小鼠免受腹膜内细菌攻击,使其大于20 LD50S(将近2 x 10(2)CFU),而未经处理的小鼠的血液中每克肝脏和肝脏每克肝脏的水平超过10(7)CFU。 。这表明这些细胞因子在宿主防御需要宿主内细菌复制的侵袭性感染中起着重要作用。这些保护机制对于毒性较低的生物可能并不重要。这些发现可能对建议的抗TNF / C药物在败血性休克治疗中的应用具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号